🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Influenza virus is a significant pathogen in pediatric solid organ transpla...
Status
Recruiting
Location
Stanford University
Start Date
2024-09-26
Trial ID
NCT05947071
Lung allograft recipients have a higher burden of influenza disease and gre...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2022-11-08
Trial ID
NCT05215327
This EPSS will determine the vaccinee reporting rates (RRs) of suspected AD...
Status
Completed
Location
Investigational Site Number : 2460001
Start Date
2023-10-02
Trial ID
NCT06059456
Treatments Being Tested
The main purpose of this Phase II study was to assess the safety and immuno...
Status
Completed
Location
Investigational Site Number :8400003
Start Date
2021-07-16
Trial ID
NCT04969276
Treatments Being Tested
In solid organ transplant (SOT) the receipt of influenza vaccine in an infl...
Status
Completed
Location
University of Minnesota
Start Date
2023-09-11
Trial ID
NCT05663463
Treatments Being Tested
This Phase 2, randomized, observer-blind, dose-confirmation clinical study ...
Status
Completed
Location
AMR Tempe
Start Date
2022-08-25
Trial ID
NCT05501561
Treatments Being Tested
This study will evaluate the relative vaccine effectiveness of quadrivalent...
Status
Recruiting
Location
Kaiser Permanente Northern California (entire region)
Start Date
2023-08-17
Trial ID
NCT06029933
Primary Objective: To demonstrate the superior relative effectiveness of Q...
Status
Terminated
Location
Investigational Site Number 2469999
Start Date
2019-11-04
Trial ID
NCT04137887
To study the effects of age on the immune system's response to flu vaccine ...
Status
Completed
Location
Vanderbilt University Medical Center
Start Date
2019-10-21
Trial ID
NCT04077424
Treatments Being Tested
This is a Phase 1, single-site, open-label, comparator-controlled dose esca...
Status
Completed
Location
Duke Vaccine and Trials Unit
Start Date
2023-04-05
Trial ID
NCT05755620